CClinicalTrials.gg
Status unknownNCT05070585IMHUpdated Dec 6, 2022

Isothiocyanates and Metabolic Health

A Phase 1/2 interventional study of Isothiocyanate rich sprouts and Placebo Juice in Metabolic Disturbance, sponsored by The Swedish School of Sport and Health Sciences. Status unknown at 1 site in Sweden. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-12-06.

Sponsored by The Swedish School of Sport and Health Sciences · Phase 1/2, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Dec 2022), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Phase 1/2
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

Many sprouts, for example broccoli sprouts, contain substances that have shown to have protective effects, both against oxidative stress and against carcinogenic substances.

In this study we will investigate the activation of the body's antioxidant defense system and effect on blood lactate and glucose after 1 week of isothiocyanate rich sprout supplementation. The subjects will perform maximal and submaximal work test, blood sampling, muscle biopsies and blood pressure monitoring post supplementation. We hypothesize that 1 week of supplementation of isothiocyanate rich sprouts alters blood lactate and glucose metabolism and activates the body's antioxidant defense system.

Read the detailed description

Many sprouts, for example broccoli sprouts, contain high levels of glucosinolates, which can be converted to the bioactive substances isothiocyanates. This conversion is assisted by another plant enzyme, myrosinase, which is released when the plant is mechanically processed. It is believed that this reaction is part of the plant's natural defense against pest insects and other animals that attack the plant in the early developmental stage. In cell and animal studies supplementation with isothiocyanates has been shown to induce the protein Nrf2 which is a so-called "Master regulator" of the body's antioxidant defenses and activates more than 200 genes that together provide a strong protection against oxidative and mutagenic stress.

In this study we will investigate Nrf2 activation in human skeletal muscle and effect on lactate-, glucose metabolism after 1 week of isothiocyanate rich sprout supplementation. The study is a double-blinded, randomized, placebo controlled, cross-over study with 4 weeks wash-out between the interventions. We will perform maximal- and submaximal work test and monitor blood glucose and lactate during the tests. Also, in the post intervention phases we will perform muscle biopsies, glucose tolerance tests and monitor blood pressure.

The hypothesis is that 1 week of isothiocyanate rich sprout supplementation activates Nrf2 in human skeletal muscle and alters blood lactate and glucose metabolism in rest and during exercise.

02

Conditions studied

  • Metabolic Disturbance

Keywords

  • Isothiocyanates
  • Blood lactate
  • Glucose regulation
  • Nrf2
03

In context

Lead sponsor

The Swedish School of Sport and Health Sciences is the lead sponsor of 12 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy volunteer
  • 18-45 years old

Exclusion criteria

Exclusion Criteria:

  • Any chronic disease
  • Inability to perform cycling exercise
  • Allergic to anesthesia
05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Isothiocyanate Rich Juice

    The juices will contain 37,5g isothiocyanate rich sprouts and be delivered frozen to the subjects. The subjects will be instructed to consume two juices per day.

    Dietary Supplement: Isothiocyanate rich sprouts

  • Placebo comparator
    Placebo Juice

    The juices will contain 37,5g alfalfa sprouts and be delivered frozen to the subjects. The subjects will be instructed to consume two juices per day.

    Dietary Supplement: Placebo Juice

Interventions

  • Dietary supplementIsothiocyanate rich sprouts

    Isothiocyanate rich sprout juice consumption for 1 week

  • Dietary supplementPlacebo Juice

    Sprout juice devoid of isothiocyanates for 1 week

06

What researchers measure

Primary outcomes

  1. Blood lactate

    Changes in blood lactate during exercise

    Time frame: Acute during sub maximal exercise

  2. Nrf2 activation

    Increased Nrf2 protein in human skeletal muscle

    Time frame: Acute after 1 week of supplementation

  3. Glucose regulation

    Improved continuous glucose control

    Time frame: Throughout 1 week of supplementation

Secondary outcomes

  1. Glucose tolerance test

    Improved glucose regulation in rest

    Time frame: 120 minutes

  2. Clinic blood pressure

    Blood pressure regulation

    Time frame: Acute after 1 week of supplementation

07

Study locations

1 site
  • Swedish School of Sports and Health Sciences
    Stockholm, 114 86, Sweden
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 6, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05070585
Lead sponsor
The Swedish School of Sport and Health Sciences
Responsible party
Sponsor
First posted
Oct 7, 2021
Start date
Oct 20, 2021
Primary completion
Dec 1, 2022
Completion
Dec 5, 2023 (estimated)
Last update
Dec 6, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion